Skip to main content
. 2021 Mar 15;203(6):689–698. doi: 10.1164/rccm.202005-1854OC

Figure 3.

Figure 3.

(A) Effect of ICS-containing therapies on the rate of decline in FEV1. The center of the diamond indicates the point estimate and the width is the 95% confidence interval (CI). (B) Effect of inhaled LABD therapy on the rate of decline in FEV1. The center of the diamond indicates the point estimate and the width is the 95% CI. COPD = chronic obstructive pulmonary disease; ICS = inhaled corticosteroid; ISOLDE = Inhaled Steroids in Obstructive Lung Disease in Europe; LABD = long-acting bronchodilator; LHS2 = Lung Health Study 2; SUMMIT = Study to Understand Mortality and Morbidity; TORCH = Toward a Revolution in COPD Health; UPLIFT = Understanding Potential Long-Term Impacts on Function with Tiotropium.